Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products

Journal of General Virology

Volumn 90, Issue 8, 2009, Pages 1906-1915

  Chambers, Raychel ^a   Takimoto, Toru ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLUENZA VACCINE; INTERFERON REGULATORY FACTOR 3; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN C; VIRUS PROTEIN V; C PROTEIN, HUMAN PARAINFLUENZA VIRUS TYPE 1; INTERFERON; NONSTRUCTURAL C PROTEIN, SENDAI VIRUS; P PROTEIN, PARAINFLUENZA VIRUS 1; P PROTEIN, SENDAI VIRUS; PHOSPHOPROTEIN;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; GENE FUNCTION; HOST RANGE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS GENE; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; CELL LINE; DRUG ANTAGONISM; GENETIC RECOMBINATION; GENETICS; IMMUNOLOGY; SENDAI VIRUS;

HUMAN PARAINFLUENZA VIRUS 1; MURINAE; PARAINFLUENZA VIRUS; SENDAI VIRUS;

ANIMALS; APOPTOSIS; CELL LINE; HUMANS; INTERFERONS; MICE; PARAINFLUENZA VIRUS 1, HUMAN; PHOSPHOPROTEINS; RECOMBINATION, GENETIC; SENDAI VIRUS; VIRAL PROTEINS;

EID: 69449105467     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.011700-0     Document Type: Article

References (37)

1. Alymova, I. V., Taylor, G., Takimoto, T., Lin, T. H., Chand, P., Babu, Y. S., Li, C., Xiong, X. & Portner, A. (2004). Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo. Antimicrob Agents Chemother 48, 1495-1502.
2. Andrejeva, J., Childs, K. S., Young, D. F., Carlos, T. S., Stock, N., Goodbourn, S. & Randall, R. E. (2004). The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter. Proc Natl Acad Sci U S A 101, 17264-17269.
3. Bartlett, E. J., Cruz, A. M., Esker, J., Castano, A., Schomacker, H., Surman, S. R., Hennessey, M., Boonyaratanakornkit, J., Pickles, R. J. & other authors (2008a). Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates. J Virol 82, 8965-8977.
4. Bartlett, E. J., Hennessey, M., Skiadopoulos, M. H., Schmidt, A. C., Collins, P. L.,Murphy, B. R. & Pickles, R. J. (2008b). Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium. J Virol 82, 8059-8070.
5. Bousse, T., Matrosovich, T., Portner, A., Kato, A., Nagai, Y. & Takimoto, T. (2002). The long noncoding region of the human parainfluenza virus type 1 F gene contributes to the read-through transcription at the M-F gene junction. J Virol 76, 8244-8251.
6. Bousse, T., Chambers, R. L., Scroggs, R. A., Portner, A. & Takimoto, T. (2006).Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment. Virus Res 121, 23-32.
7. Conzelmann, K. K. (2005). Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses. J Virol 79, 5241-5248.
8. Curran, J., Boeck, R. & Kolakofsky, D. (1991). The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J 10, 3079-3085.
9. Didcock, L., Young, D. F., Goodbourn, S. & Randall, R. E. (1999). The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73, 9928-9933.
10. Dillon, P. J. & Parks, G. D. (2007). Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. J Virol 81, 11116-11127.
11. Fuerst, T. R., Niles, E. G., Studier, F. W. & Moss, B. (1986). Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci U S A 83, 8122-8126.
12. Garcin, D., Marq, J. B., Goodbourn, S. & Kolakofsky, D. (2003). The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol 77, 2321-2329.
13. Gotoh, B., Komatsu, T., Takeuchi, K. & Yokoo, J. (2001). Paramyxovirus accessory proteins as interferon antagonists. Microbiol Immunol 45, 787-800.
14. Haller, O., Kochs, G. & Weber, F. (2006). The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344, 119-130.
15. He, B., Paterson, R. G., Stock, N., Durbin, J. E., Durbin, R. K., Goodbourn, S., Randall, R. E. & Lamb, R. A. (2002). Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-b induction and interferon signaling. Virology 303, 15-32.
16. Heylbroeck, C., Balachandran, S., Servant, M. J., DeLuca, C., Barber, G. N., Lin, R. & Hiscott, J. (2000). The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol 74, 3781-3792.
17. Iwamura, T., Yoneyama, M., Yamaguchi, K., Suhara, W., Mori, W., Shiota, K., Okabe, Y., Namiki, H. & Fujita, T. (2001). Induction of IRF-3/-7 kinase and NF-κB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6, 375-388.
18. Kato, A., Sakai, Y., Shioda, T., Kondo, T., Nakanishi, M. & Nagai, Y. (1996). Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1, 569-579.
19. Kato, A., Kiyotani, K., Sakai, Y., Yoshida, T. & Nagai, Y. (1997). The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 16, 578-587.
20. Kato, A., Cortese-Grogan, C.,Moyer, S. A., Sugahara, F., Sakaguchi, T., Kubota, T., Otsuki, N., Kohase, M., Tashiro, M. & Nagai, Y. (2004). Characterization of the amino acid residues of Sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J Virol 78, 7443-7454.
21. Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T. & other authors (2006). Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441, 101-105.
22. Kato, A., Kiyotani, K., Kubota, T., Yoshida, T., Tashiro, M. & Nagai, Y. (2007). Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol 81, 3264-3271.
23. Kiyotani, K., Sakaguchi, T., Kato, A., Nagai, Y. & Yoshida, T. (2007). Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice. Virology 359, 82-91.
24. Komatsu, T., Takeuchi, K., Yokoo, J. & Gotoh, B. (2002). Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett 511, 139-144.
25. Komatsu, T., Takeuchi, K., Yokoo, J. & Gotoh, B. (2004). C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-β production. Virology 325, 137-148.
26. Koyama, A. H., Irie, H., Kato, A., Nagai, Y. & Adachi, A. (2003). Virus multiplication and induction of apoptosis by Sendai virus: role of the C proteins. Microbes Infect 5, 373-378.
27. Matsuoka, Y., Curran, J., Pelet, T., Kolakofsky, D., Ray, R. & Compans, R. W. (1991). The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol 65, 3406-3410.
28. Peters, K., Chattopadhyay, S. & Sen, G. C. (2008). IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol 82, 3500-3508.
29. Power, U. F., Ryan, K. W. & Portner, A. (1992). The P genes of human parainfluenza virus type 1 clinical isolates are polycistronic and microheterogeneous. Virology 189, 340-343.
30. Precious, B., Young, D. F., Andrejeva, L., Goodbourn, S. & Randall, R. E. (2005). In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J Gen Virol 86, 151-158.
31. Randall, R. E. & Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1-47.
32. Sangster, M., Smith, F. S., Coleclough, C. & Hurwitz, J. L. (1995). Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection. Virology 212, 13-19.
33. Strahle, L., Marq, J. B., Brini, A., Hausmann, S., Kolakofsky, D. & Garcin, D. (2007). Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J Virol 81, 12227-12237.
34. Takimoto, T., Bousse, T. & Portner, A. (2000). Molecular cloning and expression of human parainfluenza virus type 1 L gene. Virus Res 70, 45-53.
35. Talon, J., Horvath, C. M., Polley, R., Basler, C. F., Muster, T., Palese, P. & Garcia-Sastre, A. (2000). Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74, 7989-7996.
36. Van Cleve, W., Amaro-Carambot, E., Surman, S. R., Bekisz, J., Collins, P. L., Zoon, K. C., Murphy, B. R., Skiadopoulos, M. H. & Bartlett, E. J. (2006). Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology 352, 61-73.
37. Young, D. F., Didcock, L., Goodbourn, S. & Randall, R. E. (2000). Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269, 383-390.